These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33407648)

  • 1. Surgical spacer placement for proton radiotherapy in locally advanced pancreatic body and tail cancers: initial clinical results.
    Lee D; Komatsu S; Terashima K; Toyama H; Matsuo Y; Takahashi D; Suga M; Nishimura N; Tai K; Kido M; Demizu Y; Tokumaru S; Okimoto T; Sasaki R; Fukumoto T
    Radiat Oncol; 2021 Jan; 16(1):3. PubMed ID: 33407648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
    Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
    Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico comparison of the dosimetric impacts of a greater omentum spacer for abdominal and pelvic tumors in carbon-ion, proton and photon radiotherapy.
    Yamada M; Sato H; Ieko Y; Miyasaka Y; Kanai T; Yano N; Ono T; Akamatsu H; Harada M; Ichikawa M; Teranishi Y; Kikuchi Y; Nemoto K
    Radiat Oncol; 2019 Nov; 14(1):207. PubMed ID: 31752932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the dosimetric impact of interfractional anatomical changes in photon, proton and carbon ion radiotherapy for pancreatic cancer patients.
    Houweling AC; Crama K; Visser J; Fukata K; Rasch CR; Ohno T; Bel A; van der Horst A
    Phys Med Biol; 2017 Apr; 62(8):3051-3064. PubMed ID: 28252445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose Prediction Model for Duodenum Sparing With a Biodegradable Hydrogel Spacer for Pancreatic Cancer Radiation Therapy.
    Feng Z; Rao AD; Cheng Z; Shin EJ; Moore J; Su L; Kim SH; Wong J; Narang A; Herman JM; McNutt T; Li D; Ding K
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):651-659. PubMed ID: 30031143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas.
    Thompson RF; Mayekar SU; Zhai H; Both S; Apisarnthanarax S; Metz JM; Plastaras JP; Ben-Josef E
    Med Phys; 2014 Aug; 41(8):081711. PubMed ID: 25086521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer.
    Stefanowicz S; Stützer K; Zschaeck S; Jakobi A; Troost EGC
    Radiat Oncol; 2018 Nov; 13(1):228. PubMed ID: 30466468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Spacers in Radiation Therapy for Locally Advanced Pancreatic Cancer: A Planning Study.
    Kawaguchi H; Demizu Y; Mukumoto N; Ishihara T; Miyawaki D; Komatsu S; Akasaka H; Shinoto M; Shioyama Y; Nakamura K; Fukumoto T; Sasaki R
    Anticancer Res; 2021 Jan; 41(1):503-508. PubMed ID: 33419849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of proton therapy in the treatment of large irradiation volumes: a comparative planning study of pancreatic and biliary tumors.
    Zurlo A; Lomax A; Hoess A; Bortfeld T; Russo M; Goitein G; Valentini V; Marucci L; Capparella R; Loasses A
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):277-88. PubMed ID: 10924999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity.
    Nichols RC; George TJ; Zaiden RA; Awad ZT; Asbun HJ; Huh S; Ho MW; Mendenhall NP; Morris CG; Hoppe BS
    Acta Oncol; 2013 Apr; 52(3):498-505. PubMed ID: 23477361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulated-scanning proton therapy (PT).
    Ding X; Dionisi F; Tang S; Ingram M; Hung CY; Prionas E; Lichtenwalner P; Butterwick I; Zhai H; Yin L; Lin H; Kassaee A; Avery S
    Med Dosim; 2014; 39(2):139-45. PubMed ID: 24661778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of rectal dose reduction by a hydrogel spacer among 3D conformal radiotherapy, volumetric-modulated arc therapy, helical tomotherapy, CyberKnife and proton therapy.
    Saito M; Suzuki T; Sugama Y; Marino K; Sano N; Komiyama T; Aoki S; Maehata Y; Yoshizawa K; Ashizawa K; Suzuki H; Ueda K; Miyasaka Y; Araya M; Takahashi H; Onishi H
    J Radiat Res; 2020 May; 61(3):487-493. PubMed ID: 32211861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric analysis of stereotactic rotational versus static intensity-modulated radiation therapy for pancreatic cancer.
    Cho I; Park JW; Cho B; Kwak J; Yoon SM; Nesseler JP; Park J; Kim JH
    Cancer Radiother; 2018 Dec; 22(8):754-762. PubMed ID: 30322818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer.
    Lin LL; Kirk M; Scholey J; Taku N; Kiely JB; White B; Both S
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):181-189. PubMed ID: 26372435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis.
    Makishima H; Ishikawa H; Terunuma T; Hashimoto T; Yamanashi K; Sekiguchi T; Mizumoto M; Okumura T; Sakae T; Sakurai H
    J Radiat Res; 2015 May; 56(3):568-76. PubMed ID: 25755255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
    Chao HH; Berman AT; Simone CB; Ciunci C; Gabriel P; Lin H; Both S; Langer C; Lelionis K; Rengan R; Hahn SM; Prabhu K; Fagundes M; Hartsell W; Mick R; Plastaras JP
    J Thorac Oncol; 2017 Feb; 12(2):281-292. PubMed ID: 27826034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Safety of Simultaneous Integrated Boost-Proton Beam Therapy for Localized Pancreatic Cancer.
    Kim TH; Lee WJ; Woo SM; Kim H; Oh ES; Lee JH; Han SS; Park SJ; Suh YG; Moon SH; Kim SS; Kim DY
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818783879. PubMed ID: 29962281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes.
    Grosshans DR; Zhu XR; Melancon A; Allen PK; Poenisch F; Palmer M; McAleer MF; McGovern SL; Gillin M; DeMonte F; Chang EL; Brown PD; Mahajan A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):540-6. PubMed ID: 25304948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated Robust Proton Planning Using Dose-Volume Histogram-Based Mimicking of the Photon Reference Dose and Reducing Organ at Risk Dose Optimization.
    Kierkels RGJ; Fredriksson A; Both S; Langendijk JA; Scandurra D; Korevaar EW
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):251-258. PubMed ID: 30145392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.
    Zschaeck S; Blümke B; Wust P; Kaul D; Bahra M; Riess H; Klein F; Sinn M; Pelzer U; Budach V; Ghadjar P
    PLoS One; 2017; 12(10):e0186341. PubMed ID: 29023527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.